No Arabic abstract
Data-driven automatic approaches have demonstrated their great potential in resolving various clinical diagnostic dilemmas in neuro-oncology, especially with the help of standard anatomic and advanced molecular MR images. However, data quantity and quality remain a key determinant of, and a significant limit on, the potential of such applications. In our previous work, we explored synthesis of anatomic and molecular MR image network (SAMR) in patients with post-treatment malignant glioms. Now, we extend it and propose Confidence Guided SAMR (CG-SAMR) that synthesizes data from lesion information to multi-modal anatomic sequences, including T1-weighted (T1w), gadolinium enhanced T1w (Gd-T1w), T2-weighted (T2w), and fluid-attenuated inversion recovery (FLAIR), and the molecular amide proton transfer-weighted (APTw) sequence. We introduce a module which guides the synthesis based on confidence measure about the intermediate results. Furthermore, we extend the proposed architecture for unsupervised synthesis so that unpaired data can be used for training the network. Extensive experiments on real clinical data demonstrate that the proposed model can perform better than the state-of-theart synthesis methods.
Data-driven automatic approaches have demonstrated their great potential in resolving various clinical diagnostic dilemmas for patients with malignant gliomas in neuro-oncology with the help of conventional and advanced molecular MR images. However, the lack of sufficient annotated MRI data has vastly impeded the development of such automatic methods. Conventional data augmentation approaches, including flipping, scaling, rotation, and distortion are not capable of generating data with diverse image content. In this paper, we propose a method, called synthesis of anatomic and molecular MR images network (SAMR), which can simultaneously synthesize data from arbitrary manipulated lesion information on multiple anatomic and molecular MRI sequences, including T1-weighted (T1w), gadolinium enhanced T1w (Gd-T1w), T2-weighted (T2w), fluid-attenuated inversion recovery (FLAIR), and amide proton transfer-weighted (APTw). The proposed framework consists of a stretch-out up-sampling module, a brain atlas encoder, a segmentation consistency module, and multi-scale label-wise discriminators. Extensive experiments on real clinical data demonstrate that the proposed model can perform significantly better than the state-of-the-art synthesis methods.
Noninvasive MR-guided focused ultrasound (MRgFUS) treatments are promising alternatives to the surgical removal of malignant tumors. A significant challenge is assessing the viability of treated tissue during and immediately after MRgFUS procedures. Current clinical assessment uses the nonperfused volume (NPV) biomarker immediately after treatment from contrast-enhanced MRI. The NPV has variable accuracy, and the use of contrast agent prevents continuing MRgFUS treatment if tumor coverage is inadequate. This work presents a novel, noncontrast, learned multiparametric MR biomarker that can be used during treatment for intratreatment assessment, validated in a VX2 rabbit tumor model. A deep convolutional neural network was trained on noncontrast multiparametric MR images using the NPV biomarker from follow-up MR imaging (3-5 days after MRgFUS treatment) as the accurate label of nonviable tissue. A novel volume-conserving registration algorithm yielded a voxel-wise correlation between treatment and follow-up NPV, providing a rigorous validation of the biomarker. The learned noncontrast multiparametric MR biomarker predicted the follow-up NPV with an average DICE coefficient of 0.71, substantially outperforming the current clinical standard (DICE coefficient = 0.53). Noncontrast multiparametric MR imaging integrated with a deep convolutional neural network provides a more accurate prediction of MRgFUS treatment outcome than current contrast-based techniques.
Diffusion-weighted (DW) magnetic resonance imaging is essential for the diagnosis and treatment of ischemic stroke. DW images (DWIs) are usually acquired in multi-slice settings where lesion areas in two consecutive 2D slices are highly discontinuous due to large slice thickness and sometimes even slice gaps. Therefore, although DWIs contain rich 3D information, they cannot be treated as regular 3D or 2D images. Instead, DWIs are somewhere in-between (or 2.5D) due to the volumetric nature but inter-slice discontinuities. Thus, it is not ideal to apply most existing segmentation methods as they are designed for either 2D or 3D images. To tackle this problem, we propose a new neural network architecture tailored for segmenting highly-discontinuous 2.5D data such as DWIs. Our network, termed LambdaUNet, extends UNet by replacing convolutional layers with our proposed Lambda+ layers. In particular, Lambda+ layers transform both intra-slice and inter-slice context around a pixel into linear functions, called lambdas, which are then applied to the pixel to produce informative 2.5D features. LambdaUNet is simple yet effective in combining sparse inter-slice information from adjacent slices while also capturing dense contextual features within a single slice. Experiments on a unique clinical dataset demonstrate that LambdaUNet outperforms existing 3D/2D image segmentation methods including recent variants of UNet. Code for LambdaUNet will be released with the publication to facilitate future research.
Thermal ablation is a minimally invasive procedure for treat-ing small or unresectable tumors. Although CT is widely used for guiding ablation procedures, the contrast of tumors against surrounding normal tissues in CT images is often poor, aggravating the difficulty in accurate thermal ablation. In this paper, we propose a fast MR-CT image registration method to overlay a pre-procedural MR (pMR) image onto an intra-procedural CT (iCT) image for guiding the thermal ablation of liver tumors. By first using a Cycle-GAN model with mutual information constraint to generate synthesized CT (sCT) image from the cor-responding pMR, pre-procedural MR-CT image registration is carried out through traditional mono-modality CT-CT image registration. At the intra-procedural stage, a partial-convolution-based network is first used to inpaint the probe and its artifacts in the iCT image. Then, an unsupervised registration network is used to efficiently align the pre-procedural CT (pCT) with the inpainted iCT (inpCT) image. The final transformation from pMR to iCT is obtained by combining the two estimated transformations,i.e., (1) from the pMR image space to the pCT image space (through sCT) and (2) from the pCT image space to the iCT image space (through inpCT). Experimental results confirm that the proposed method achieves high registration accuracy with a very fast computational speed.
Medical Imaging is one of the growing fields in the world of computer vision. In this study, we aim to address the Diabetic Retinopathy (DR) problem as one of the open challenges in medical imaging. In this research, we propose a new lesion detection architecture, comprising of two sub-modules, which is an optimal solution to detect and find not only the type of lesions caused by DR, their corresponding bounding boxes, and their masks; but also the severity level of the overall case. Aside from traditional accuracy, we also use two popular evaluation criteria to evaluate the outputs of our models, which are intersection over union (IOU) and mean average precision (mAP). We hypothesize that this new solution enables specialists to detect lesions with high confidence and estimate the severity of the damage with high accuracy.